Top Stories
The company emerged from stealth Thursday with undisclosed pre-seed backing from MAVRK Celestia Fund, Kern Venture Group and Digital Neural Infrastructure Holdings.
CMR-CLIP was trained on more than 11,000 cardiac MRI studies and outperformed AI systems adapted from broader imaging tasks by more than 35% in some tests.
The combined firm will back companies across pharmaceuticals, medical devices, life science tools, diagnostics, healthcare infrastructure and healthcare IT.
One of the drugmaker's main goals is to make its wealth of scientific, clinical, regulatory and commercial expertise easy to surface.
The MyLabcorp app is built with OpenAI models to help users better understand their health information and identify patterns over time.
Conference News
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) Breakthrough meeting will bring together global oncology professionals in Asia to discuss the latest cancer research advances across ...
Experts also present findings on factors limiting access to cancer clinical trials22-May-2026 at 10:54 AM EDT, by Roswell Park Comprehensive Cancer Center contact patient servicesHighlightsDr. Eunice ...
Artificial intelligence, GLP-1s, CAR T cell therapy, and cancer genetics star in Penn’s ASCO research.22-May-2026 at 8:00 AM EDT, by Perelman School of Medicine at the University of Pennsylvania conta...
IRVING, Texas, May 22, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Caris, the Caris Precision O...
Meeting AnnouncementECOG-ACRIN Cancer Research GroupResearchers affiliated with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) are set to unveil new findings from a diverse portfolio of clinical tr...
